Sutimlimab

Sutimlimab Suppliers list
Company Name: Aladdin Scientific
Tel: +1-+1(833)-552-7181
Email: sales@aladdinsci.com
Products Intro: Product Name:Sutimlimab (anti-C1s)
CAS:2049079-64-1
Purity:Purity>95% (SDS-PAGE&SEC); Endotoxin Level<0.01EU/μg; Human Package:$69.9/100μg;Bulk package Remarks:Purity>95% (SDS-PAGE&SEC); Endotoxin Level<0.01EU/μg; Human IgG4SP; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated
Company Name: ShangHai Biochempartner Co.,Ltd  
Tel: 17754423994 17754423994
Email: 2853530910@QQ.com
Products Intro: Product Name:Sutimlimab
CAS:2049079-64-1
Purity:95% Package:100ug;500ug;1mg
Company Name: Beijing Solarbio Science & Tecnology Co., Ltd.  
Tel: 010-50973130 4009686088
Email: 3193328036@qq.com
Products Intro: CAS:2049079-64-1
Company Name: Guangzhou Hongyuan Chemical Co.,Ltd  
Tel: 15817493340
Email: 981810490@qq.com
Products Intro: Product Name:Sutimlimab
CAS:2049079-64-1
Purity:95% Package:1mg;1g;100g
Company Name: Wuhan Chemstan Biotechnology Co., Ltd.  
Tel: 027-65317797 15926423062
Email: 422450190@qq.com
Products Intro: Product Name:Sutimlimab
Purity:>95%;1mg/ml Package:200ug;500ug;1mg
Sutimlimab Basic information
Product Name:Sutimlimab
Synonyms:Sutimlimab;Sutimlimab (DHC43601);Research Grade Sutimlimab(DHC43601);Sutimlimab (anti-C1s)
CAS:2049079-64-1
MF:
MW:0
EINECS:
Product Categories:
Mol File:Mol File
Sutimlimab Structure
Sutimlimab Chemical Properties
storage temp. Store at -20°C
form Liquid
color Colorless to light yellow
Safety Information
MSDS Information
Sutimlimab Usage And Synthesis
Biological ActivitySutimlimab, a first-in-class humanized immunoglobulin G4 (IgG4) monoclonal antibody that selectively inhibits the classical complement pathway at C1s, rapidly halted hemolysis in the single-arm CARDINAL study in recently transfused patients with cold agglutinin disease (CAD).
Sutimlimab Preparation Products And Raw materials
Tag:Sutimlimab(2049079-64-1) Related Product Information
Urelumab varlilumab Eptinezumab Atezolizumab Obinutuzumab Utomilumab Glofitamab Nesvacumab Odronextamab Rituximab